04/19/2024 3:31 PM | Gilead Sciences (Reporting) LEAP THERAPEUTICS, INC. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/19/2024 3:31 PM | Gilead Sciences (Filed by) LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13G | |
04/05/2024 3:31 PM | Gilead Sciences (Filed by) Xilio Therapeutics, Inc. (Subject)
| Form SC 13G | |
04/03/2024 5:48 PM | Gilead Sciences (Reporting) Xilio Therapeutics, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/03/2024 5:50 PM | Gilead Sciences (Reporting) Xilio Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 5:38 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2024 4:19 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/28/2024 3:07 PM | Gilead Sciences (Filer)
| Form DEF 14A | |
03/28/2024 3:07 PM | Gilead Sciences (Filer)
| Form DEFA14A | |
03/22/2024 8:21 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 6:50 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/20/2024 3:12 PM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/15/2024 3:11 PM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
03/12/2024 3:19 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:11 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:14 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:59 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:03 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:34 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T/A | |
02/29/2024 5:35 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:49 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 3:38 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 5:09 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-T | |
02/13/2024 4:48 PM | Gilead Sciences (Reporting) Kyverna Therapeutics, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 7:37 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 7:39 AM | CymaBay Therapeutics, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC TO-C | |
02/09/2024 5:21 PM | Capital World Investors (Filed by) Gilead Sciences (Subject)
| Form SC 13G/A | |
02/07/2024 4:35 PM | Gilead Sciences (Reporting) Kyverna Therapeutics, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/06/2024 5:01 PM | Gilead Sciences (Issuer) LOVE TED W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:20 PM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 1:42 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:34 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:19 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 1:11 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 12:40 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 3:58 PM | Arcus Biosciences, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC 13D/A | |
01/31/2024 4:00 PM | Arcus Biosciences, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 1:27 PM | BlackRock Inc. (Filed by) Gilead Sciences (Subject)
| Form SC 13G/A | |
01/17/2024 5:01 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 3:32 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:35 PM | Gilead Sciences (Subject) Mercier Johanna (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad) This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate…
And a cumulative gain of 1729%.
How does it all work? Click Here To Get Your Free Copy |
12/29/2023 3:36 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/28/2023 4:06 PM | Arcellx, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC 13G/A | |
12/28/2023 4:09 PM | Arcellx, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/22/2023 3:07 PM | Gilead Sciences (Reporting) HOOKIPA Pharma Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/11/2023 6:00 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:04 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:08 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:10 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 6:15 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 5:21 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 4:18 PM | Gilead Sciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023 4:56 PM | Gilead Sciences (Issuer) Telman Deborah H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/25/2023 6:15 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer) Gilead Sciences (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/25/2023 4:18 PM | ASSEMBLY BIOSCIENCES, INC. (Subject) Gilead Sciences (Filed by)
| Form SC 13D | |
10/19/2023 2:33 PM | Gilead Sciences (Filed by) Ikena Oncology, Inc. (Subject)
| Form SC 13G | |
10/18/2023 3:31 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:18 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2023 7:09 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 8:00 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 5:50 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:21 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 7:37 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 7:40 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 7:44 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 7:11 PM | Gilead Sciences (Issuer) O'Day Daniel Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 7:19 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 3:09 PM | Gilead Sciences (Filer)
| Form 424B5 | |
09/07/2023 4:28 PM | Gilead Sciences (Subject)
| Form FWP | |
09/07/2023 7:29 AM | Gilead Sciences (Filer)
| Form 424B5 | |
08/16/2023 4:19 PM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/04/2023 4:23 PM | Gilead Sciences (Filer)
| Form S-3ASR | |
07/25/2023 5:15 PM | Gilead Sciences (Issuer) Mercier Johanna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/21/2023 4:30 PM | Dickinson Andrew D (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 8:38 AM | Arcus Biosciences, Inc. (Subject) Gilead Sciences (Filed by)
| Form SC 13D/A | |
06/30/2023 2:54 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2023 2:12 PM | Arcus Biosciences, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 4:17 PM | Allovir, Inc. (Issuer) Gilead Sciences (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 4:48 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2023 4:29 PM | Gilead Sciences (Subject) Parsey Merdad (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023 3:45 PM | Gilead Sciences (Issuer) Parsey Merdad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:50 PM | Gilead Sciences (Issuer) Patterson Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2023 10:15 AM | Gilead Sciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 6:10 PM | BARTON JACQUELINE K (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 6:15 PM | Gilead Sciences (Issuer) Kramer Kelly A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 5:02 PM | Gilead Sciences (Issuer) Horning Sandra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 5:13 PM | Bluestone Jeffrey (Reporting) Gilead Sciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 4:47 PM | Gilead Sciences (Issuer) WELTERS ANTHONY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 4:51 PM | Gilead Sciences (Issuer) MANWANI HARISH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 4:53 PM | Gilead Sciences (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/04/2023 4:57 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
This AI Trade Machine Made 1,729%* (With 89% Wins) (Ad) This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate…
And a cumulative gain of 1729%.
How does it all work? Click Here To Get Your Free Copy |
05/02/2023 6:12 PM | Gilead Sciences (Issuer) Lofton Kevin E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |